Biogen

Team Biogen took part in the Alzheimer's Association Walk to End Alzheimer's to raise awareness and hear inspiring stories from community members impacted by this disease. These stories of resilience and courage drive our commitment to combat Alzheimer's disease (AD) and continue pushing forward scientific advancements.    See how we’re addressing AD through research and innovation: https://ow.ly/3gfL50U35y5   #TeamBiogen | #ENDALZ | #Walk2EndAlz 

With patient safety as the first priority, we recognize the critical role of pharmacovigilance. During this year´s #MedSafetyWeek, we’re emphasizing the importance of using medicines correctly and reporting adverse events when they occur.     Learn more about Med Safety Week 2024: https://ow.ly/xHBf50TZFxP   #MedSafetyWeek | #PatientSafety  

This morning, we reported our Q3 financial results. Learn more here: https://ow.ly/4Uj750TWvR2   #Earnings | #BIIB |#FinancialResults 

STARTING SOON: Join our Q3 2024 financial results live webcast at 8:30 AM ET. Join here: https://ow.ly/KoA550TVQjb #Earnings | #BIIB | #FinancialResults

Biogen will report Q3 2024 financial results today before markets open in the U.S.: https://lnkd.in/eNG9cf8S    #News | #Earnings | $BIIB

With Neomorph, Inc., we announced a new multi-target research collaboration to discover and develop molecular glue degraders for Alzheimer’s, rare, and immunological diseases. Learn more about this announcement: https://lnkd.in/ePQWJuPy #News

We’re attending the Clinical Trials on Alzheimer’s Disease (CTAD) 2024 annual conference to present the latest data from our research portfolio.    We are also highlighting ongoing advancements in Alzheimer’s disease (AD) including research on the role of tau in AD. Visit KnowTau.com to learn more.   #CTAD24 | #Biogen | #AlzheimersResearch

Torniamo a parlare oggi di “Rassegnati tu! Io ballo con Friedreich”, il docufilm realizzato da Biogen con il Patrocinio di AISA ODV e lo facciamo attraverso la storia di Giulio, il secondo protagonista di questo viaggio unico ed emozionante che ci condurrà alla scoperta di cosa significa convivere con l’Atassia di Friedreich, una malattia neurodegenerativa rara di origine genetica ed ereditaria. Giulio ci racconta di cosa ha significato per lui ricevere la diagnosi e in che modo è riuscito a reagire. La forza l’ha trovata nel pugilato che per lui è diventata una vera e propria filosofia di vita: «ogni giorno la malattia prova a buttarti al tappeto, ma tu ti rialzi e reagisci», racconta Giulio. Guarda la storia di Giulio e segui il nostro viaggio di conoscenza e consapevolezza dedicato all’Atassia di Friedreich. #FriedreichAtassia #Atassia #IoBalloconFriedreich

Today we celebrate World Psoriasis Day 2024 with the theme "Family." Psoriasis affects millions worldwide and having a support system can be important for managing this condition. Whether it's emotional support, understanding, or helping with daily care, that support can be crucial for those living with psoriasis. Learn more about World Psoriasis Day: https://ow.ly/r2gm50TVusH #WorldPsoriasisDay2024 | #FamilySupport | #PsoriasisAwareness

Welcome to Biogen, Daniel Quirk, MD, MPH, MBA!   Today, we announced the addition of Dr. Quirk to our team as our new Chief Medical Officer and Head of Medical Affairs.     We are pleased to welcome Dr. Quirk, a highly accomplished medical professional with a diverse background in medicine, public health, and business administration. With this appointment, Dr. Quirk becomes the newest member of the Biogen Executive Leadership Team. Read the news: https://ow.ly/2u9p50TVsST   #News | #TeamBiogen